Bausch Health Companies Inc. EBITDA for the year ending December 31, 2024: USD 1.55 B

Bausch Health Companies Inc. EBITDA is USD 1.55 B for the year ending December 31, 2024, a -31.06% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2023 was USD 2.24 B, a -14.44% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2022 was USD 2.62 B, a 35.32% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2021 was USD 1.94 B, a -24.14% change year over year.
  • Bausch Health Companies Inc. EBITDA for the year ending December 31, 2020 was USD 2.55 B, a 34.87% change year over year.
Key Data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)